The nation of Zimbabwe has rejected a major American healthcare agreement worth $367m (272 million pounds) spanning five years due to the United States' demand for confidential data.
The decision was revealed after a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesman has since explained that the United States was requesting health data for research and commercial gain while refused to guarantee the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for further talks to secure a deal acceptable to both sides so the country's vital HIV programme can continue.
Broader Background
This development follows a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the safety of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and accountability.
According to reports, Sixteen nations in Africa have so far signed these new health pacts, representing over $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently on HIV treatment through US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its biological resources and data indefinitely, with no equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"Effectively, our nation would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our population should a future health crisis emerge."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting structures previously established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This system is intended to guarantee that when a country provides its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to further dialogue with our American counterparts on how subsequent collaboration could be structured in a manner that respects the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but urged that negotiations need to persist since much of the nation's Aids initiatives depended on external financing.
"In cases where technical issues exist, including those involving data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," the group added.
The situation highlights the ongoing debate between receiving vital international aid and protecting a country's data in an increasingly data-driven world.